Señales en vivo de 0503.HK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 nov 2023 @ 03:08):

Stats
Volumen de hoy	13.96M
Volumen promedio	476 561
Capitalización de mercado	750.60M
EPS	HKD0 ( 2023-08-24 )
Last Dividend	HKD1.497 ( 2021-09-13 )
Next Dividend	HKD0 ( N/A )
P/E	13.77
ATR14	HKD0.0150 (0.84%)

Volumen Correlación

Largo: 0.09 (neutral)

Corto: 0.00 (neutral)

Signal:(54.908) Neutral

Lansen Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lansen Pharmaceutical Correlación - Moneda/Commodity

-0.27
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.36
( neutral )

0.18
( neutral )

Lansen Pharmaceutical Finanzas

Annual	2022
Ingresos:	HKD65.56M
Beneficio Bruto:	HKD44.30M (67.57 %)
EPS:	HKD0.0205

FY	2022
Ingresos:	HKD65.56M
Beneficio Bruto:	HKD44.30M (67.57 %)
EPS:	HKD0.0205

FY	2021
Ingresos:	HKD54.18M
Beneficio Bruto:	HKD34.41M (63.51 %)
EPS:	HKD0.00224

FY	2020
Ingresos:	HKD54.39M
Beneficio Bruto:	HKD35.18M (64.68 %)
EPS:	HKD0.218

Financial Reports:

No articles found.

Lansen Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Lansen Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.21 - good (82.09%) | Divividend Growth Potential Score: 2.16 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0136	2011-04-20
Last Dividend	HKD1.497	2021-09-13
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	HKD2.55	--
Avg. Dividend % Per Year	0.00%	--
Score	2.25	--
Div. Sustainability Score	8.21
Div.Growth Potential Score	2.16
Div. Directional Score	5.19	--

Next Divdend (Est)
(2024-07-15)

HKD0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

2.25

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3393.HK	Ex Dividend Knight	2023-05-18	Annually	0.00%
1598.HK	Ex Dividend Junior	2023-07-13	Annually	0.00%
0636.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
9928.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
2180.HK	Ex Dividend Knight	2023-07-03	Annually	0.00%
1181.HK	Ex Dividend Knight	2023-09-13	Annually	0.00%
0257.HK	Ex Dividend Junior	2023-09-25	Semi-Annually	0.00%
3888.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
1755.HK	Ex Dividend Knight	2023-07-03	Annually	0.00%
0798.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.114	1.500	7.72	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0424	1.200	8.59	10.00	[0 - 0.3]
returnOnEquityTTM	0.0604	1.500	-0.440	-0.661	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.54	0.800	2.28	1.820	[1 - 3]
quickRatioTTM	1.500	0.800	5.88	4.71	[0.8 - 2.5]
cashRatioTTM	0.939	1.500	5.89	8.84	[0.2 - 2]
debtRatioTTM	0.101	-1.500	8.31	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00596	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00460	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.144	-1.500	9.43	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.660	1.000	2.33	2.33	[0.2 - 0.8]
operatingProfitMarginTTM	0.191	1.000	8.18	8.18	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.142	1.000	-0.323	-0.323	[0.2 - 2]
assetTurnoverTTM	0.371	0.800	-0.859	-0.687	[0.5 - 2]
Total Score				8.21

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.03	1.000	8.78	0	[1 - 100]
returnOnEquityTTM	0.0604	2.50	-0.283	-0.661	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00460	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00596	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00938	1.500	-3.27	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0388	1.000	-1.530	0	[0.1 - 0.5]
Total Score				2.16

Lansen Pharmaceutical

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.